3 Reasons to Avoid NOC and 1 Stock to Buy Instead

via StockStory
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

NOC Cover Image

Northrop Grumman has been treading water for the past six months, recording a small loss of 2.1% while holding steady at $560.06. The stock also fell short of the S&P 500’s 7.1% gain during that period.

Is there a buying opportunity in Northrop Grumman, or does it present a risk to your portfolio? Get the full stock story straight from our expert analysts, it’s free.

Why Do We Think Northrop Grumman Will Underperform?

We're sitting this one out for now. Here are three reasons why NOC doesn't excite us and a stock we'd rather own.

1. Long-Term Revenue Growth Disappoints

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Over the last five years, Northrop Grumman grew its sales at a sluggish 2.6% compounded annual growth rate. This was below our standards.

Northrop Grumman Quarterly Revenue

2. Projected Revenue Growth Is Slim

Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite.

Over the next 12 months, sell-side analysts expect Northrop Grumman’s revenue to rise by 5.4%. Although this projection suggests its newer products and services will catalyze better top-line performance, it is still below the sector average.

3. EPS Barely Growing

We track the long-term change in earnings per share (EPS) because it highlights whether a company’s growth is profitable.

Northrop Grumman’s weak 3.1% annual EPS growth over the last five years aligns with its revenue performance. On the bright side, this tells us its incremental sales were profitable.

Northrop Grumman Trailing 12-Month EPS (Non-GAAP)

Final Judgment

We cheer for all companies making their customers lives easier, but in the case of Northrop Grumman, we’ll be cheering from the sidelines. With its shares trailing the market in recent months, the stock trades at 20× forward P/E (or $560.06 per share). At this valuation, there’s a lot of good news priced in - we think there are better stocks to buy right now. We’d suggest looking at the most entrenched endpoint security platform on the market.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article